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Hydrogen peroxide and organic hydroperoxides react with haemoglobin to release iron which can be com- 
plexed to apotransferrin, bleomycin and desferrioxamine. This released iron promotes deoxyribose degrada- 
tion by a Fenton reaction, DNA degradation in the presence of bleomycin and stimulates lipid peroxidation. 
It is likely that iron released from haemoglobin is the true generator of hydroxyl radicals in the Fenton 
reaction. 
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1. INTRODUCTION 
The highly reactive and biologically damaging 
hydroxyl radical (OH’) can be formed in biological 
material when suitable transition metal ion 
catalysts are available (reviews [I ,2]). The most 
abundant metal ion likely to catalyse this reaction 
is iron. Normally, iron is transported and stored in 
specific proteins which prevent, or minimise, its 
reaction with reduced oxygen metabolites. 
However, in spite of these safeguards increasing 
evidence suggests that reactive iron becomes 
available during disease states [3]. Studies have 
shown that the specific iron chelator desferriox- 
amine can modify tissue changes observed in in- 
~ammatory, degenerative and ischaemic damage 
as well as organ storage for transplantation [4-71. 
Several reports have suggested that haemoglobin 
[8] and the iron-binding proteins transferrin [9] 
and lactoferrin [lo] can act as catalysts for the Fen- 
ton reaction, although the experiments performed 
with haemoglobin were inadequate in that the only 
evidence for OH’ radicai participation in the 
system under study was inhibition by thiourea [8] 
which is not a specific scavenger of OH‘. I show 
here that iron bound to haemoglobin is unlikely to 
produce OH‘ radicals in free solution, but that 
peroxides can cause a release of iron from the pro- 
tein. This released iron, which can be bound by 
transferrin or desferrioxamine, is the true pro- 
moter of OH‘ generation and contributes to perox- 
idation in haemoglobin-containing systems. 
2. MATERIALS AND METHODS 
2.1. Materials 
Catalase (bovine liver, 17000 units/mg protein, 
thymol-free), albumin (human, fatty acid-free), 
apotransferrin (human), haemoglobin (human), 
caeruloplasmin (human), 2-deoxy-D-ribose, tert- 
butyI-hydroperoxide were from Sigma, Poole, 
Dorset. Units of enzyme activity were as defined in 
the Sigma catalogue. Haptoglobin (human, mixed 
types) was from Calbiochem, and desferrioxamine 
from Ciba-Geigy. All other chemicals were of the 
highest purity available from BDH, Poole. 
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2.2. Measurement of iron release from 
haemoglobin by peroxides 
Haemoglobin (1 mg/ml) dissolved in Chelex 
resin-treated ion-free water was further treated 
with Chelex resin using a batch technique to 
remove any loosely bound iron salts. 0.1 ml of this 
solution was incubated with hydrogen peroxide or 
organic hydroperoxides as indicated in fig.1 and 
table 1. Iron released from haemoglobin during the 
incubation was measured by the ferrozine or 
bleomycin methods [ 11,121. 
2.3. Deoxyribose degradation 
Deoxyribose in phosphate buffer (pH 7.4) was 
incubated for 2 h at 37°C with haemoglobin and 
hydrogen peroxide under the conditions shown in 
table 2. Inhibitors were added before HzOz. After 
incubation, thiobarbituric acid (TBA) reactivity 
was developed by adding 0.5 ml TBA (l%, w/v, in 
0.05 M NaOH) and 0.5 ml trichloroacetic acid 
(2.8%, w/v) then heating at 100°C for 10 min. The 
resulting chromogen was extracted into butan-l-01 
and relative fluorescence intensity (RFI) measured 
at excitation 532 nm and emission 553 nm using a 
reference standard of rhodamine B. 
2.4. Lipid peroxidation 
Linolenic acid micelles were prepared by vortex- 
mixing 10 ~1 fatty acid in 10 ml phosphate-saline 
buffer, pH 7.4 (0.025 M sodium phosphate in 
0.15 M NaCl). Micelles were substituted for deox- 
yribose and incubated as described in section 2.3 
with haemoglobin and hydrogen peroxide. Full 
details are given in table 3. After incubation, 
0.5 ml TBA reagent and 1.0 ml acid buffer (pH 
3.5) were added and the tube contents heated at 
100°C for 20 min. The resulting chromogen was 
extracted into butan-l-01 and measured as de- 
scribed above for deoxyribose. 
3. RESULTS 
Iron was released from haemoglobin after in- 
cubation with Hz02 or organic hydroperoxides. 
This iron could be measured by the ferrozine 
method (fig.1). In the case of H202, the results 
were confirmed with the more sensitive bleomycin 
assay (fig. 1). Unfortunately, organic hydroperox- 
ides interfere with the bleomycin assay and so it 
could not be used in their presence. The slightly 
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Fig. 1. Haemoglobin (1 mg/ml) was incubated at 37°C 
for 2 h with peroxide at the different final reaction 
concentrations indicated. At the end of the incubation 
period, 50 ~1 catalase (0.5 mg/ml) was added to destroy 
any remaining H202. Standard curves were established 
with ferric chloride and the amount of iron released 
from haemoglobin determined by the ferrozine and 
bleomycin methods. (0) Haemoglobin incubated with 
Hz02 and released iron measured by the bleomycin 
method. (m) Haemoglobin incubated with Hz02 and 
released iron measured by the ferrozine method. (0) 
Haemoglobin incubated with tert-butyl-hydroperoxide 
and the released iron measured by the ferrozine method. 
(0) Haemoglobin incubated with cumene hydroperoxide 
and the released iron measured by the ferrozine method. 
higher levels of iron obtained by the bleomycin 
method are ascribed to its greater sensitivity. 
Catalase prevented the release of iron from 
haemoglobin but did not inhibit the detection of an 
iron salt in the bleomycin assay. Apotransferrin 
and desferrioxamine, however, completely 
prevented the detection of bleomycin-available 
iron (table 1). Albumin, added as a control for 
non-specific protein effects, showed no significant 
inhibition of iron release from haemoglobin or of 
the reaction of released iron with bleomycin (table 
1). The haem-binding protein haptoglobin weakly 
inhibited the peroxide-dependent release of iron 
from haemoglobin (table 1) but had no effect on 
an iron salt. 
The iron released from haemoglobin by Hz02 
accelerated eoxyribose degradation and this could 
be detected and measured using the sensitive 
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Table 1 Table 2 
Release of iron from haemoglobin in the presence of Deoxyribose degradation stimulated by haemoglobin in 
Hz02 and its availability for binding to bleomycin: the the presence of hydrogen peroxide: the effect of 
effect of inhibitors on iron release and binding inhibitors 
Iron (uM) % in- 
available hibition 
to of iron 
bleomycin released or 
detected 
(1) Control haemoglobin 
(0.17 mg/ml) 
(2) Haemoglobin + Hz02 
(0.8 mM) 
Reaction 2 + catalase 
(0.08 mg/ml) 
Reaction 2 + albumin 
(0.17 mg/ml) 
Reaction 2 + haptoglobin 
(0.17 mg/ml) 
Reaction 2 + transferrin 
(1 .O mg/ml) 
Reaction 2 + desferrioxamine 
(0.17 mM) 
0 
23.4 
0 100 
23.1 NS 
19.5 17 
0 100 
0 100 
0.1 ml haemoglobin (1 mg/ml) was incubated with 
0.1 ml Hz02 (5 mM) in a volume of 0.6 ml for 2 h at 
37°C. lo/cl catalase (0.5 mg/ml) was added to destroy 
any remaining peroxide. 0.1 ml of the inhibitors at the 
concentration shown above were added to the reaction 
before the addition of Hz02. After incubation, an 
aliquot of the mixture was sampled for the bleomycin 
assay. Iron standards and appropriate blanks were 
similarly treated. Results shown are the mean of 3 
separate assays which differed by less than f 5%: NS, 
not significant. Final reaction concentrations are shown 
fluorimetric TBA reaction. The deoxyribose 
degradation was strongly inhibited by catalase, 
apotransferrin, desferrioxamine or caeruloplasmin 
and to a lesser extent by the OH’ scavenger man- 
nitol. Hence Hz02 is involved not only in the 
release of iron but also in the formation of OH’ 
radicals (table 2). Albumin showed no significant 
inhibitory activity. Iron released from 
haemoglobin also stimulated the peroxidation of 
linolenic acid micelles. The peroxidation was in- 
hibited by catalase, apotransferrin, desferriox- 
amine, propyl gallate and caeruloplasmin (table 3). 
OH’ radicals detected 
as the formation of 
TBA reactivity after 
deoxyribose degrada- 
tion (Ex.532 nm, 
Em.553 nm) 
Fluo- % inhi- 
rescence bition of 
(RF1 units) fluo- 
rescence 
(1) Deoxyribose only 
(2) Deoxyribose + Hz02 
(0.67 mM) 
(3) Deoxyribose + ferric 
chloride (6.7 FM) 
(4) Deoxyribose + ferric 
chloride + Hz02 
(5) Deoxyribose + haemo- 
globin (133 pg/ml) 
(6) Deoxyribose + haemo- 
globin + Hz02 
Reaction 6 + catalase 
(67 pg/ml) 
Reaction 6 + albumin 
(133 pg/ml) 
Reaction 6 + transferrin 
(800 pg/ml) 
Reaction 6 + desferrioxamine 
(133 PM) 
Reaction 6 + caeruloplasmin 
(133 /g/ml) 
Reaction 6 + mannitol 
(13.3 PM) 
2 
7 
3 
16 
7 
41 
9 94 
40 NS 
17 71 
8 97 
15 76 
19 65 
All reactions contained 6.7 /IM deoxyribose and 53 mM 
phosphate buffer (pH 7.4). Results were calculated after 
the subtraction of the haemoglobin blank. Final reaction 
concentrations are shown. The results are a mean of 3 
separate assays which differed by less than + 5%. NS, 
not significant 
4. DISCUSSION 
Suggestions that the haemoglobin molecule is a 
catalyst for the biological Fenton reaction [S] do 
not appear to be compatible with the known 
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Table 3 
Fatty acid peroxidation stimulated by haemoglobin in 
the presence of hydrogen peroxide: the effect of 
inhibitors 
Linolenic acid peroxi- 
dation as TBA 
reactivity (Ex.532 nm, 
Em.553 nm) 
Fluo- % inhi- 
rescence bition of 
(RF1 units) fluo- 
rescence 
(1) Fatty acid only 20 
(2) Fatty acid + Hz02 
(1.1 mM) 22 
(3) Fatty acid + haemoglobin 
(110 fig/ml) 21 
(4) Fatty acid + haemo- 
globin + Hz02 31 
Reaction 4 + catalase 
(60 @g/ml) 21 100 
Reaction 4 + albumin 
(100 pg/mI) 37 NS 
Reaction 4 + caeruloplasmin 
(200 pg/ml) 25 75 
Reaction 4 + transferrin 
(1.7 mg/ml) 22 94 
Reaction 4 + desferrioxamine 
(100 PM) 18 100 
Reaction 4 + propyl gallate 
(100 PM) 17 108 
All reactions contained 0.2 ml linolenic acid micelles and 
40 mM phosphate buffer (pH 7.4). Final reaction 
concentrations are shown. Results are the mean of 3 
separate assays which differed by less than 5% and were 
calculated after the subtraction of appropriate blank 
values. NS, not significant 
chemistry of the OH’ radical since this implies that 
OH’ formed at the iron centre travels through the 
protein core into free solution to react with a detec- 
tor molecule. Studying the oxidative breakdown of 
haemoglobin some 50 years ago, Lemberg and col- 
leagues [13,14] observed that ‘labile iron’ was 
released during the oxidative sequence. 
Recently, loosely bound iron released from 
haem-protein and ferritin has been shown to ac- 
count for an important part of the observed 
stimulatory properties towards lipid peroxidation 
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of these proteins [15-181. Extending these studies 
it is here shown that both Hz02 and organic 
hydroperoxides can oxidatively degrade 
haemoglobin with the release of iron. It is this iron 
not the haem iron or the protein which is able to 
promote OH’ formation. 
These findings support the view that low- 
molecular-mass iron complexes are the most likely 
Fenton catalysts in vivo and point to a major 
source of such iron. Using the bleomycin-iron 
assay loosely bound iron has been detected in 
fluids taken from patients with degenerative brain 
disease [191, active joint disease [20], iron overload 
[2 1,221 and exercise-stressed athletes 1231. ‘Mal- 
placed’ iron likely to stimulate radical reactions 
can arise as a consequence of tissue damage or iron 
overload. In addition, the iron-promoted forma- 
tion of OH’ radicals and lipid peroxidation is also 
likely to occur as a direct result of increased ox- 
ygen radical formation in the presence of haemo- 
globin released from protected sites. 
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